Exenatide: all 231 studies that test it

Page 3 of 3. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.

• The Effects of Exenatide After Gastric RestrictionStatus unknownNCT00872378Phase 2/3
• The Effects of Exenatide on Post-Meal Sugar Peaks and Vascular Health in Obese/Pre-Diabetic Young AdultsWithdrawnNCT00845559Phase 4
• Pharmacological Postconditioning to Reduce Infarct Size Following Primary PCICompletedNCT00835848Phase 4
• Effects of Exenatide in Type 2 Diabetic Patients With Congestive Heart FailureCompletedNCT00766857Phase 4
• The Effect of the GLP-1 Analogue Exenatide on Type 2 Diabetes in CNS and Heart During Hyperglycemia Assessed by PETCompletedNCT00747968Phase 2/3
• PREDnisolone-induced Beta-cell Dysfunction Prevented by EXenatideCompletedNCT00744224Not applicable
• Electrophysiological Effects of a Single 10 μg Dose of Exenatide on the 12-Lead Electrocardiogram QT Interval in Healthy SubjectsCompletedNCT00672399Phase 1
• A Study to Examine Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Exenatide Once Weekly in Japanese Patients With Type 2 DiabetesCompletedNCT00612794Phase 1
• Pilot Study of Exenatide Pharmacokinetics and Pharmacodynamics in Gestational DiabetesWithdrawnNCT00572689Phase 4
• Gut Derived Hormones, Body Composition and Metabolism in Prader-Willi SyndromeCompletedNCT00551343Not applicable
• A Study to Compare the Effects of Exenatide and Sitagliptin on Postprandial Glucose in Subjects With Type 2 Diabetes MellitusCompletedNCT00477581Phase 4
• A Study to Assess the Effect on Glucose Control and Safety and Tolerability of LY2148568 In Japanese Patients With Type 2 DiabetesCompletedNCT00382239Phase 2
• Safety and Efficacy of Exenatide as MonotherapyCompletedNCT00381342Phase 3
• Comparison of Exenatide Taken Before Lunch and Dinner With Before Breakfast and Dinner in Patients With Type 2 DiabetesCompletedNCT00359879Phase 3
• Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Metformin or Sulfonylureas and MetforminCompletedNCT00324363Phase 3
• Effects of Biphasic Insulin Aspart 70/30 vs. Exenatide in Type 2 Diabetes Patients Not Reaching Blood Glucose Targets on Metformin and a Sulfonylurea.CompletedNCT00313001Phase 3
• In-patient Study in Patients With Type 2 Diabetes MellitusCompletedNCT00259896Phase 1
• The Effects of Exenatide on Oral Contraceptive Pharmacokinetics in Healthy FemalesCompletedNCT00254800Phase 1
• Effect of Exenatide on 24-Hour Blood Glucose Profile Compared With Placebo in Patients With Type 2 DiabetesCompletedNCT00241423Phase 2
• Study to Examine the Effect on Glucose Control and Safety/Tolerability of Exenatide Given Two Times a Day to Subjects With Type 2 DiabetesCompletedNCT00111540Phase 3
• Study Examining Exenatide Long-Acting Release in Subjects With Type 2 DiabetesCompletedNCT00103935Phase 2
• Comparing Exenatide and Insulin Glargine in Type 2 Diabetes Patients for Whom Insulin is the Next Appropriate TherapyCompletedNCT00099619Phase 3
• Study of the Safety of Substituting Exenatide for Insulin in Patients Using Insulin and Oral Antidiabetic AgentsCompletedNCT00099333Phase 2
• Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and MetforminCompletedNCT00099320Phase 3
• Effect of Exenatide Monotherapy on Glucose Control in Subjects With Type 2 Diabetes MellitusCompletedNCT00085969Phase 2
• Effect of AC2993 With or Without Immunosuppression on Beta Cell Function in Patients With Type I DiabetesCompletedNCT00064714Phase 2
• Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes MellitusCompletedNCT00044694Phase 2
• Evaluation of the Effect on Glucose Control and Safety of AC2993 in Patients With Type 2 Diabetes Treated With Metformin, Sulfonylurea, or Metformin and Sulfonylurea CombinationCompletedNCT00044668Phase 3
• Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With a SulfonylureaCompletedNCT00039026Phase 3
• Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With MetforminCompletedNCT00039013Phase 3
• Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes MellitusCompletedNCT00035984Phase 3

← Exenatide overview